Or. Admin. Code § 855-080-0085 - Prescription Requirements
(1)
Registrants, practitioners and Pharmacists as specified therein in the
issuance, preparation, labeling, dispensing, recordkeeping and filing of
prescriptions for controlled substances must comply with the provisions of
21 CFR
1306.01 (04/01/2023),
21 CFR
1306.02 (04/01/2023),
21 CFR
1306.03 (04/01/2023),
21 CFR
1306.04 (04/01/2023),
21 CFR
1306.05 (04/01/2023),
21 CFR
1306.06 (04/01/2023),
21 CFR
1306.07 (04/01/2023),
21 CFR
1306.08 (04/01/2023),
21 CFR
1306.09 (04/01/2023);
21 CFR
1306.11 (04/01/2023),
21 CFR
1306.12 (04/01/2023),
21 CFR
1306.13 (04/01/2023),
21 CFR
1306.14 (04/01/2023),
21 CFR
1306.15 (04/01/2023);
21 CFR
1306.21 (04/01/2023),
21 CFR
1306.22 (04/01/2023);
21 CFR
1306.23 (04/01/2023),
21 CFR
1306.24 (04/01/2023),
21 CFR
1306.25 (04/01/2023),
21 CFR
1306.27 (04/01/2023); and
21 CFR
1304.03(d)
(04/01/2023).
(2) Controlled
substances listed in 21 CFR
1308.15 (04/01/2023) as schedule V are
prescription drugs.
(3)
Pseudoephedrine and ephedrine may be:
(a)
Provided to a patient without a prescription under ORS
475.230.
(4) For a Schedule II controlled substance
prescription, a Pharmacist may:
(a) Add the
patient's address based on information provided by the patient or patient's
agent with appropriate verification;
(b) Amend or add the following information
after consultation with and agreement of the prescriber:
(A) Drug strength;
(B) Dosage form;
(C) Drug quantity;
(D) Directions for use;
(E) Prescriber's address; and
(F) Prescriber's DEA registration
number.
(c) Amend the
following information after consultation with and agreement of the prescriber,
the:
(A) Date the prescription was issued;
and
(B) Date the prescription can
be filled.
(d) For (b)
and (c), the Pharmacist must document on the prescription the date of the
prescriber's authorization, the amendment or addition authorized, and the
Pharmacist's identity.
(5) For a Schedule II controlled substance
prescription, a Pharmacist must not change the patient's name, the controlled
substance prescribed except for generic substitution, and the name or signature
of the prescriber.
Notes
Publications: Publications referenced are available for review at the agency.
Statutory/Other Authority: ORS 689.205
Statutes/Other Implemented: ORS 475.185 & ORS 475.188
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.